NCT00121134 Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer Status COMPLETED Phase NA
NCT00119314 Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin Status WITHDRAWN Phase PHASE2
NCT00119171 Ispinesib In Combination With Capecitabine In Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00118755 A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00118300 Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer Status WITHDRAWN Phase PHASE1
NCT00118105 S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT00114816 Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer Status COMPLETED Phase PHASE3
NCT00114231 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer Status COMPLETED Phase PHASE2
NCT00114179 Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00114153 Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00113230 Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer Status COMPLETED Phase PHASE2
NCT00112918 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE3
NCT00107393 Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00107315 Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00107276 S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00107250 AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) Status COMPLETED Phase PHASE1
NCT00104689 Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00100815 Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE2